Prospective assessment of genetic effects on progression to different stages of age-related macular degeneration using multistate Markov models.

PURPOSE Understanding the effect of genes on progression to different stages of age-related macular degeneration (AMD) may suggest stage-specific therapeutic targets and more precise prediction of the development of this disease. METHODS Progression events and time to each stage of AMD were derived from the longitudinal data of 2560 subjects without advanced AMD. SNPs in 12 AMD risk loci were genotyped. A multistate Markov model for progression from normal to intermediate drusen, then to large drusen, and eventually to neovascular disease (NV) or geographic atrophy (GA) was applied to estimate stage-specific hazard ratios for each SNP. The effects of these genetic factors were also estimated by a multivariate multistate Markov model adjusted for baseline age, sex, smoking, body mass index (BMI), education, antioxidant treatment, and the status of AMD in the fellow eye. RESULTS Controlling for demographic and behavioral factors and other SNPs, the TT genotype of rs10468017 in LIPC was associated with decreased risk of progression from large drusen to NV (HR = 0.57, P = 0.04) and tended to reduce the risk of progression from normal to intermediate drusen (HR = 0.72, P = 0.07). The SNP rs1883025 (T allele) in ABCA1 was associated with decreased risk of progression from normal to intermediate drusen (HR per allele = 0.82 per allele, P = 9.7 × 10(-3)) and from intermediate drusen to large drusen (HR per allele = 0.77, P = 5.2 × 10(-3)). The genes CFH, C3, CFB, and ARMS2/HTRA1 were associated with progression from intermediate drusen to large drusen and from large drusen to GA or NV. CONCLUSIONS Genes in different pathways influence progression to different stages of AMD.

[1]  Aaron Y. Lee,et al.  Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene (LIPC) , 2010, Proceedings of the National Academy of Sciences.

[2]  B. Rosner,et al.  Cigarette smoking, fish consumption, omega-3 fatty acid intake, and associations with age-related macular degeneration: the US Twin Study of Age-Related Macular Degeneration. , 2006, Archives of ophthalmology.

[3]  E. Souied,et al.  [Epidemiology of age related macular degeneration]. , 2009, Journal Francais d'Ophtalmologie.

[4]  B. Rosner,et al.  Associations of smoking, body mass index, dietary lutein, and the LIPC gene variant rs10468017 with advanced age-related macular degeneration , 2010, Molecular vision.

[5]  Ronald Klein,et al.  The epidemiology of age-related macular degeneration. , 2004, American journal of ophthalmology.

[6]  T. Peto,et al.  The symmetry of phenotype between eyes of patients with early and late bilateral age-related macular degeneration (AMD) , 2011, Graefe's Archive for Clinical and Experimental Ophthalmology.

[7]  L. D. Del Priore,et al.  Drusen in age-related macular degeneration: pathogenesis, natural course, and laser photocoagulation-induced regression. , 1999, Survey of ophthalmology.

[8]  M. Daly,et al.  Variation near complement factor I is associated with risk of advanced AMD , 2009, European Journal of Human Genetics.

[9]  Yun Li,et al.  CFH haplotypes without the Y402H coding variant show strong association with susceptibility to age-related macular degeneration , 2006, Nature Genetics.

[10]  R. T. Smith,et al.  A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[11]  A. Edwards,et al.  Complement Factor H Polymorphism and Age-Related Macular Degeneration , 2005, Science.

[12]  Christine A Curcio,et al.  The oil spill in ageing Bruch membrane , 2011, British Journal of Ophthalmology.

[13]  Johanna M Seddon,et al.  Risk models for progression to advanced age-related macular degeneration using demographic, environmental, genetic, and ocular factors. , 2011, Ophthalmology.

[14]  Hein Putter,et al.  The mstate package for estimation and prediction in non- and semi-parametric multi-state and competing risks models , 2010, Comput. Methods Programs Biomed..

[15]  Margaret A. Pericak-Vance,et al.  Genetic variants near TIMP3 and high-density lipoprotein–associated loci influence susceptibility to age-related macular degeneration , 2010, Proceedings of the National Academy of Sciences.

[16]  D. Weeks,et al.  Susceptibility genes for age-related maculopathy on chromosome 10q26. , 2005, American journal of human genetics.

[17]  N. Camp,et al.  A Variant of the HTRA1 Gene Increases Susceptibility to Age-Related Macular Degeneration , 2006, Science.

[18]  J. Gilbert,et al.  Complement Factor H Variant Increases the Risk of Age-Related Macular Degeneration , 2005, Science.

[19]  Aaron Y. Lee,et al.  Common variants near FRK/COL10A1 and VEGFA are associated with advanced age-related macular degeneration , 2011, Human molecular genetics.

[20]  B. Rosner,et al.  Serum lipid biomarkers and hepatic lipase gene associations with age-related macular degeneration. , 2010, Ophthalmology.

[21]  Lars G Fritsche,et al.  Evidence of association of APOE with age‐related macular degeneration ‐ a pooled analysis of 15 studies , 2011, Human mutation.

[22]  Johanna M Seddon,et al.  Common variation in three genes, including a noncoding variant in CFH, strongly influences risk of age-related macular degeneration , 2006, Nature Genetics.

[23]  Joan W. Miller,et al.  Albert & Jakobiec's principles and practice of ophthalmology , 2008 .

[24]  Chi Pui Pang,et al.  HTRA1 promoter polymorphism in wet age-related macular degeneration. , 2007, Science.

[25]  M. Killingsworth,et al.  Early drusen formation in the normal and aging eye and their relation to age related maculopathy: a clinicopathological study , 1999, The British journal of ophthalmology.

[26]  I. Deary,et al.  Complement C3 variant and the risk of age-related macular degeneration. , 2007, The New England journal of medicine.

[27]  A. Linneberg,et al.  Small, hard macular drusen and peripheral drusen: associations with AMD genotypes in the Inter99 Eye Study. , 2010, Investigative ophthalmology & visual science.

[28]  H Putter,et al.  Tutorial in biostatistics: competing risks and multi‐state models , 2007, Statistics in medicine.

[29]  R. T. Smith,et al.  Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration , 2006, Nature Genetics.

[30]  Johanna M Seddon,et al.  Evaluation of the clinical age-related maculopathy staging system. , 2006, Ophthalmology.

[31]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[32]  Johanna M Seddon,et al.  Prediction model for prevalence and incidence of advanced age-related macular degeneration based on genetic, demographic, and environmental variables. , 2009, Investigative ophthalmology & visual science.

[33]  Johanna M Seddon,et al.  Variation in complement factor 3 is associated with risk of age-related macular degeneration , 2007, Nature Genetics.

[34]  S. Fisher,et al.  Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk , 2005 .

[35]  M. Daly,et al.  Association of variants in the LIPC and ABCA1 genes with intermediate and large drusen and advanced age-related macular degeneration. , 2011, Investigative ophthalmology & visual science.

[36]  B. J. Klevering,et al.  Basal laminar drusen caused by compound heterozygous variants in the CFH gene. , 2008, American journal of human genetics.